Resmed Inc. buy KeyCorp
Start price
06.02.24
/
50%
€178.25
Target price
06.02.25
€211.50
Performance (%)
28.64%
End price
07.02.25
€229.30
Summary
This prediction ended on 07.02.25 with a price of €229.30. The prediction had a final performance of 28.64%. KeyCorp has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Dividends of €1.87 are taken into consideration when calculating the performance. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -0.181% | -0.181% | -2.608% |
| iShares Core DAX® | 0.760% | -0.301% | 17.507% |
| iShares Nasdaq 100 | 0.732% | -1.001% | 9.349% |
| iShares Nikkei 225® | 1.025% | -3.621% | 12.862% |
| iShares S&P 500 | -0.036% | -0.194% | 3.758% |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $227.00 price target on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von KeyCorp gewählte maximale Laufzeit wurde überschritten